Predictors of Failed Thrombolysis in Acute Myocardial Infarction
Predictors of Failed Thrombolysis in Acute ST-segment Elevation Myocardial Infarction
Oslo University Hospital
200 participants
Apr 25, 2022
OBSERVATIONAL
Conditions
Summary
The purpose of this observational study is to assess why thrombolytic treatment with tissue-plasminogen activator (t-PA) fails in patients with acute ST-segment elevation myocardial infarction (STEMI). The study will include 200 STEMI patients at the time of arrival at Oslo University Hospital Ullevål after receiving prehospital thrombolysis. A blood sample will be taken immediately for the study of factors related to coagulation, fibrinolysis and inflammation. Levels of the biomarkers will be compared between patients with successful and failed thrombolysis.
Eligibility
Inclusion Criteria1
- STEMI patients > 18 years given prehospital thrombolysis.
Exclusion Criteria1
- None.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Biomarker levels will be compared between patients with successful and failed thrombolysis.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05347732